Acrivon Therapeutics upgraded to Buy on cancer data at Ladenburg
PremiumThe FlyAcrivon Therapeutics upgraded to Buy on cancer data at Ladenburg
2M ago
Acrivon Therapeutics upgraded to Buy from Neutral at Ladenburg
Premium
The Fly
Acrivon Therapeutics upgraded to Buy from Neutral at Ladenburg
2M ago
Acrivon reports data from ongoing ACR-368 registrational intent Phase 2 study
Premium
The Fly
Acrivon reports data from ongoing ACR-368 registrational intent Phase 2 study
2M ago
ACRV Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsACRV Upcoming Earnings Report: What to Expect?
3M ago
Acrivon Therapeutics price target raised to $22 from $20 at H.C. Wainwright
Premium
The Fly
Acrivon Therapeutics price target raised to $22 from $20 at H.C. Wainwright
6M ago
Acrivon Therapeutics reports Q1 EPS (73c), consensus (84c)
Premium
The Fly
Acrivon Therapeutics reports Q1 EPS (73c), consensus (84c)
6M ago
Acrivon Therapeutics Inc trading halted, volatility trading pause
PremiumThe FlyAcrivon Therapeutics Inc trading halted, volatility trading pause
7M ago
Acrivon Therapeutics price target raised to $30 from $26 at Piper Sandler
Premium
The Fly
Acrivon Therapeutics price target raised to $30 from $26 at Piper Sandler
7M ago
Acrivon Therapeutics price target raised to $17 from $14 at JMP Securities
Premium
The Fly
Acrivon Therapeutics price target raised to $17 from $14 at JMP Securities
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100